Published in Transplantation on October 01, 1992
A prospective randomized trial of FK506-based immunosuppression after renal transplantation. Transplantation (1995) 2.09
Combined pancreas and kidney transplantation normalizes protein metabolism in insulin-dependent diabetic-uremic patients. J Clin Invest (1994) 0.76
New immunosuppressive drugs: needs in and applications to pediatric transplantation. Eur J Pediatr (1992) 0.75
Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64
Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44
Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24
Current status of clinical islet transplantation. Transplantation (2005) 4.17
Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05
Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery (1972) 3.26
Iatrogenic alterations of immunologic surveillance in man and their influence on malignancy. Transplant Rev (1971) 2.94
No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts. Lancet (1998) 2.91
Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet (2002) 2.76
Scandiatransplant: thirty years of cooperation in organ transplantation in the Nordic countries. Clin Transpl (1998) 2.73
Clinical reactions and serologic changes after the administration of heterologous antilymphocyte globulin to human recipients of renal homografts. Ann Intern Med (1968) 2.72
Kidney donors live longer. Transplantation (1997) 2.61
Studies of blood flow and ultrastructural changes in rejecting and nonrejecting canine orthotopic liver homografts. Surgery (1968) 2.58
Specific bacteriologic problems after orthotopic liver transplantation in dogs and pigs. Arch Surg (1968) 2.32
Heterologous antilymphocyte glubulin, histoincompatiblity matching, and human renal homotransplantation. Surg Gynecol Obstet (1968) 2.23
Integrated care for the elderly: the background and effects of the reform of Swedish care of the elderly. Int J Integr Care (2000) 2.16
An everting technique for intraluminal vascular suturing. Surg Gynecol Obstet (1968) 2.12
HLA-matching and pretransplant blood transfusions in cadaveric renal transplantation--a changing picture with cyclosporin. Lancet (1986) 2.08
Coagulation during and after orthotopic transplantation of the human liver. Arch Surg (1969) 2.03
Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet (1993) 2.00
Infections in recipients of liver homografts. N Engl J Med (1968) 1.92
Urological complications in 216 human recipients of renal transplants. Ann Surg (1970) 1.90
Damage to porcine islets of Langerhans after exposure to human blood in vitro, or after intraportal transplantation to cynomologus monkeys: protective effects of sCR1 and heparin. Transplantation (2000) 1.83
Hemodynamic alterations caused during orthotopic liver transplantation in humans. Surgery (1971) 1.79
Platelet changes following clinical and experimental hepatic homotransplantation. Arch Surg (1968) 1.78
Cyclophosphamide and human organ transplantation. Lancet (1971) 1.77
Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes. Ups J Med Sci (2000) 1.74
Metabolic effects of hepatic replacement in Wilson's disease. Transplant Proc (1973) 1.73
Alopecia, ascites, and incomplete regeneration after 85 to 90 per cent liver resection. Am J Surg (1975) 1.72
Changes in serum haptoglobin and group specific component after orthotopic liver homotransplantation in humans. Proc Soc Exp Biol Med (1968) 1.68
Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? Diabetes (1999) 1.65
Changes in coagulation and fibrinolysis after orthotopic canine liver homotransplantation. J Lab Clin Med (1969) 1.63
Steroid diabetes--a sign of overtreatment with steroids in the renal graft recipient? Scand J Urol Nephrol Suppl (1980) 1.63
Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met30). Clin Genet (1991) 1.60
Longstanding groin pain in athletes. A multidisciplinary approach. Sports Med (1988) 1.60
Surgically correctable intra-abdominal complications before and after renal homotransplantation. Ann Surg (1968) 1.56
Combined report on regular dialysis and transplantation in Europe, XX, 1989. Nephrol Dial Transplant (1991) 1.56
Report on management of renal failure in Europe, XXII, 1991. Nephrol Dial Transplant (1992) 1.53
HLA-D associated alloantisera react with molecules similar to Ia antigens. Proc Natl Acad Sci U S A (1977) 1.52
Geographical prevalence, risk factors and impact of hepatitis B and C after renal transplantation. Clin Nephrol (2009) 1.51
Fooled by blood cyclosporin levels. Bone Marrow Transplant (1992) 1.46
Strong association between the HLA-Dw3-related B cell alloantigen -DRw3 and coeliac disease. Scand J Gastroenterol (1978) 1.43
[Further centralization of pediatric heart surgery is recommended]. Lakartidningen (1994) 1.40
Role of hyaluronan in acute pancreatitis. Surgery (2000) 1.39
Drug metabolism in human liver in vitro: establishment of a human liver bank. Clin Pharmacol Ther (1980) 1.39
Effects of combined pancreatic and renal transplantation on diabetic neuropathy: a two-year follow-up study. Lancet (1987) 1.38
SUCCESSFUL ORTHOTOPIC TRANSPLANTATION OF LIVER HOMOGRAFTS AFTER EIGHT TO TWENTY-FIVE HOURS PRESERVATION. Surg Forum (1967) 1.37
Positron emission tomography in clinical islet transplantation. Am J Transplant (2009) 1.37
Autopsy findings in a long-surviving liver recipient. N Engl J Med (1973) 1.36
Resolution of hyperparathyroidism, renal osteodystrophy and metastatic calcification after renal homotransplantation. N Engl J Med (1968) 1.36
Correction of hyperbilirubinemia in the glucuronyltransferase-deficient rat by intraportal hepatocyte transplantation. Transplant Proc (1977) 1.35
Immunological and catalytic quantitation of splenic glucocerebrosidase from the three clinical forms of Gaucher disease. Am J Hum Genet (1983) 1.33
Improvements in the preparation of heterologous antilymphocyte globulin with special reference to absorption and diethylaminoethyl cellulose batch production. Surgery (1969) 1.29
A comparative study of the influence of malignant tumor on host metabolism in mice and man: evaluation of an experimental model. Cancer (1978) 1.29
Studies of cytomegalovirus infection in renal allograft recipients. Scand J Infect Dis (1982) 1.27
Deterioration in glucose metabolism in pancreatic transplant recipients given cyclosporin. Lancet (1983) 1.26
Intravenous foscarnet for the treatment of severe cytomegalovirus infection in allograft recipients. Scand J Infect Dis (1985) 1.25
Acute pancreatitis and hyperamylasemia in renal homograft recipients. Arch Surg (1972) 1.24
Optimising islet engraftment is critical for successful clinical islet transplantation. Diabetologia (2007) 1.21
Depletion of T lymphocytes from human bone marrow. Use of magnetic monosized polymer microspheres coated with T-lymphocyte-specific monoclonal antibodies. Transplantation (1987) 1.20
Hypertriglyceridemia in renal transplant recipients treated with sirolimus. Transplant Proc (1998) 1.19
Perspectives in organ transplantation. Antibiot Chemother (1969) 1.19
Experience with human liver grafts obtained after donor cardiac standstill. Transplant Proc (1987) 1.18
Aluminium accumulation and immunosuppressive effect in recipients of kidney transplants. BMJ (1988) 1.17
Renal replacement therapy in patients with diabetic nephropathy, 1980-1985. Report from the European Dialysis and Transplant Association Registry. Nephrol Dial Transplant (1988) 1.16
Improved survival in patients with insulin-dependent diabetes mellitus and end-stage diabetic nephropathy 10 years after combined pancreas and kidney transplantation. Transplantation (1999) 1.16
Successful pregnancies in women on renal replacement therapy: report from the EDTA Registry. Nephrol Dial Transplant (1992) 1.14
Quality of life in diabetic patients after combined pancreas-kidney or kidney transplantation. Diabetes (1989) 1.14
The pancreas transplant program--Gothenburg, Sweden. Transplant Proc (1987) 1.13
Prevention of kidney graft diabetic nephropathy by pancreas transplantation in man. Diabetes (1985) 1.13
Successful outcome of segmental human pancreatic transplantation with enteric exocrine diversion after modifications in technique. Lancet (1982) 1.12
Effects of FK506 and cyclosporin A on cytokine production studied in vitro at a single-cell level. Immunology (1992) 1.12
Serum complement after orthotopic transplantation of the human liver. Clin Exp Immunol (1972) 1.12
Splenic transplantation in a case of Gaucher's disease. Lancet (1971) 1.12
The impact of acute rejection episodes on long-term graft function and outcome in 1347 primary renal transplants treated by 3 cyclosporine regimens. Transplantation (1993) 1.12
Ischemic heart disease--major cause of death and graft loss after renal transplantation in Scandinavia. Transplantation (1995) 1.11
Kinetics and dynamics of single oral doses of sirolimus in sixteen renal transplant recipients. Ther Drug Monit (1997) 1.10
Some characteristics of steroid diabetes: a study in renal-transplant recipients receiving high-dose corticosteroid therapy. Diabetes Care (1983) 1.10
Attempted spleen transplant in classical hemophilia. Transplantation (1969) 1.09
Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases. Neurosci Lett (2000) 1.08
Renal transplantation in the Bardet-Biedl syndrome, a form of Laurence-Moon-Biedl syndrome. Nephrol Dial Transplant (1991) 1.08
Landmarks in clinical renal transplantation. Surg Gynecol Obstet (1972) 1.08
Ten years' experience of bone marrow transplantation for Gaucher disease. Transplantation (1995) 1.07
Implementation of service screening with mammography in Sweden: from pilot study to nationwide programme. J Med Screen (2000) 1.07
Platelet-derived growth factor receptors in the kidney--upregulated expression in inflammation. Kidney Int (1989) 1.07
Antiserum inhibition of the mixed lymphocyte culture (MLC) interaction. Inhibitory effect of antibodies reactive with HLA-D-associated determinants. Cell Immunol (1977) 1.05
Outcome of renal transplantation in patients over the age of 60: a case-control study. Nephrol Dial Transplant (1995) 1.05
The diagnosis and treatment of hyperparathyroidism after renal homotransplantation. Surg Gynecol Obstet (1973) 1.04
Cyclophosphamide for clinical renal and hepatic transplantation. Transplant Proc (1973) 1.04
A randomised study of allogeneic transplantation with stem cells from blood or bone marrow. Bone Marrow Transplant (2000) 1.03
Relationship of food intake, body composition, and tumor growth to host metabolism in nongrowing mice with sarcoma. Cancer Res (1980) 1.03
Immunologic diagnosis of kidney rejection using FACS analysis of graft-infiltrating functional and activated T and NK cell subsets. Transplantation (1989) 1.02
Liver transplantation in familial amyloidotic polyneuropathy. Follow-up of the first 20 Swedish patients. Transplantation (1995) 1.02